Bristol-Myers Squibb Co (NYSE:BMY)
| 58.08 Delayed Data As of Oct 20 |  +0.49 / +0.85%Today’s Change | 56.66 Today|||52-Week Range 69.75 | -6.37% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 57.59 |
| Today’s open | 57.91 |
| Day’s range | 57.90 - 58.59 |
| Volume | 9,010,325 |
| Average volume (3 months) | 9,380,857 |
| Market cap | $129.7B |
Data as of 4:00pm ET, 10/20/2021
Growth & Valuation
| Earnings growth (last year) | -297.94% |
| Earnings growth (this year) | +16.05% |
| Earnings growth (next 5 years) | +5.60% |
| Revenue growth (last year) | +62.62% |
| P/E ratio | NM |
| Price/Sales | 3.29 |
| Price/Book | 3.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +1.05 | +2.18% |
| GSKGlaxoSmithKline | +0.28 | +0.71% |
| ZTSZoetis Inc | +1.90 | +0.93% |
| ---- |
Data as of 4:04pm ET, 10/20/2021
Financials
| Next reporting date | October 27, 2021 |
| EPS forecast (this quarter) | $1.93 |
| Annual revenue (last year) | $42.5B |
| Annual profit (last year) | -$9.0B |
| Net profit margin | -21.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
